These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes. Isidori AM; Cornacchione M; Barbagallo F; Di Grazia A; Barrios F; Fassina L; Monaco L; Giannetta E; Gianfrilli D; Garofalo S; Zhang X; Chen X; Xiang YK; Lenzi A; Pellegrini M; Naro F Cardiovasc Res; 2015 Jun; 106(3):408-20. PubMed ID: 25852085 [TBL] [Abstract][Full Text] [Related]
7. Heterologous desensitization of cardiac β-adrenergic signal via hormone-induced βAR/arrestin/PDE4 complexes. Shi Q; Li M; Mika D; Fu Q; Kim S; Phan J; Shen A; Vandecasteele G; Xiang YK Cardiovasc Res; 2017 May; 113(6):656-670. PubMed ID: 28339772 [TBL] [Abstract][Full Text] [Related]
8. Selective changes in cytosolic β-adrenergic cAMP signals and L-type Calcium Channel regulation by Phosphodiesterases during cardiac hypertrophy. Abi-Gerges A; Castro L; Leroy J; Domergue V; Fischmeister R; Vandecasteele G J Mol Cell Cardiol; 2021 Jan; 150():109-121. PubMed ID: 33184031 [TBL] [Abstract][Full Text] [Related]